EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Advances in natural products and antibody drugs for SLE: new therapeutic ideas

Yibing Han, Lingwei Liu, Bo Zang, Ruiwen Liang, Xinyue Zhao, Bin Liu

Frontiers in Pharmacology · 10.07.2023 · 14

DOI: 10.3389/fphar.2023.1235440 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 10.07.2023. Verfasst von Yibing Han und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology, The Affiliated Hospital of Qingdao University, Shandong, China. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 126 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Shandong Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Systemic Lupus Erythematosus (SLE) is a chronic autoimmune systemic disease with a wide range of clinical symptoms, complex development processes, and uncertain prognosis. The clinical treatment of SLE is mainly based on hormones and immunosuppressants. Research on novel therapy strategies for SLE has flourished in recent years, especially the emergence of new targeted drugs and natural products that can modulate related symptoms. This review discusses the current experience including B-cell targeted drugs (belimumab, tabalumab, blisibimod, atacicept, rituximab, ofatumumab, ocrelizumab, obexelimab, and epratuzumab), T-cell targeted drugs (abatacept, dapirolizumab, and inhibitor of syk and CaMKIV), cytokines targeted drugs (anifrolumab and sifalimumab), and natural products (curcumin, oleuropein, punicalagin, sulforaphane, icariin, apigenin, and resveratrol). The aim of this paper is to combine the existing in vitro and in vivo models and clinical research results to summarize the efficacy and mechanism of natural drugs and targeted drugs in SLE for the reference and consideration of researchers.

Schlagwörter

Stichwörter der Autor:innen

antibody drugimmune systemnatural productssystemic lupus erythematosustreatment

Autor:innen und Institutionen

  • Department of Rheumatology, The Affiliated Hospital of Qingdao University, Shandong, China.

Förderung

  • Natural Science Foundation of Shandong Province
  • National Natural Science Foundation of China

Zitieren

APA

Han, Y., Liu, L., Zang, B., Liang, R., Zhao, X., & Liu, B. (2023). Advances in natural products and antibody drugs for SLE: new therapeutic ideas. Frontiers in Pharmacology, 14. https://doi.org/10.3389/fphar.2023.1235440

Vancouver

Han Y, Liu L, Zang B, Liang R, Zhao X, Liu B. Advances in natural products and antibody drugs for SLE: new therapeutic ideas. Frontiers in Pharmacology. 2023;14. doi:10.3389/fphar.2023.1235440

BibTeX
@article{Han2023,
  author = {Han, Yibing and Liu, Lingwei and Zang, Bo and Liang, Ruiwen and Zhao, Xinyue and Liu, Bin},
  title = {Advances in natural products and antibody drugs for SLE: new therapeutic ideas},
  journal = {Frontiers in Pharmacology},
  year = {2023},
  volume = {14},
  doi = {10.3389/fphar.2023.1235440}
}
Kostenlos starten →